Saturday, July 11, 2026

pharma · Persistent Corneal Epithelial Defect (PCED) · Recent onset Type 1 Diabetes

Doppel Farmaceutici

Dompe' Farmaceutici S.p.A is a pharma organization headquartered in MILANO, IT. Primary therapeutic focus areas include Persistent Corneal Epithelial Defect (PCED), Recent onset Type 1 Diabetes, Spastic Cerebral Palsy, C

Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli HQ
1994 Founded
393 Employees
EMA registrant Type
Company details
Status
Public
HQ
Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli
Founded
1994
Employees
393
Programs
11
Drugs
14
Patents
0
Clinical program

DF2755A-HV-101

Phase 1 · other · interstitial cystitis/bladder pain syndrome

DF2755A-HV-101 for interstitial cystitis/bladder pain syndrome is a Phase 1 program (other) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).

Internal code DF2755A-HV-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Dompe' Farmaceutici S.p.A.
Phase
Phase 1
Modality
other
Indication
interstitial cystitis/bladder pain syndrome
Status
active
Trials
1

Clinical trials